| |
| |
|
| Insider
Information: |
Sachdev Amit |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
71,325 |
|
|
Indirect Shares
|
7,447 |
|
|
| Direct
Value |
$24,204,134 |
|
|
|
Indirect Value
|
$3,257,988 |
|
|
| Total
Shares |
78,772 |
|
|
| Total
Value |
$27,462,122 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-02-26 |
55,325 |
2024-02-26 |
7,447 |
Premium* |
|
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP Chief Patient & Ext Af Off |
• – – |
2023-11-15 |
4 |
AS |
$369.92 |
$12,947 |
D/D |
(35) |
58,814 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-11-16 |
4 |
AS |
$222.50 |
$9,388 |
D/D |
(42) |
35,103 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-05-17 |
4 |
AS |
$215.59 |
$9,736 |
D/D |
(45) |
40,133 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-11-15 |
4 |
AS |
$186.78 |
$9,547 |
D/D |
(51) |
31,928 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2019-11-15 |
4 |
AS |
$205.95 |
$11,739 |
D/D |
(57) |
33,416 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-05-15 |
4 |
AS |
$274.67 |
$16,496 |
D/D |
(58) |
35,103 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-11-15 |
4 |
AS |
$163.75 |
$9,989 |
D/D |
(61) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2019-05-15 |
4 |
AS |
$165.41 |
$10,090 |
D/D |
(61) |
33,416 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-11-15 |
4 |
AS |
$147.29 |
$12,225 |
D/D |
(83) |
50,710 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-05-15 |
4 |
AS |
$155.78 |
$12,930 |
D/D |
(83) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2015-11-16 |
4 |
AS |
$122.28 |
$10,394 |
D/D |
(85) |
78,963 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2016-11-15 |
4 |
AS |
$93.36 |
$10,830 |
D/D |
(116) |
86,096 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-05-15 |
4 |
AS |
$114.37 |
$13,267 |
D/D |
(116) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2016-05-16 |
4 |
AS |
$81.67 |
$9,555 |
D/D |
(117) |
86,096 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2015-05-15 |
4 |
AS |
$123.85 |
$16,224 |
D/D |
(131) |
84,901 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2014-11-17 |
4 |
AS |
$111.97 |
$15,004 |
D/D |
(134) |
78,671 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
• – – |
2011-01-11 |
4 |
AS |
$37.66 |
$16,985 |
D/D |
(451) |
39,838 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-05-06 |
4 |
AS |
$275.28 |
$184,162 |
D/D |
(669) |
35,103 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-05-06 |
4 |
OE |
$131.89 |
$88,234 |
D/D |
669 |
35,772 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
• – – |
2009-05-18 |
4 |
AS |
$28.44 |
$22,269 |
D/D |
(783) |
40,366 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Public Policy,Gov Affairs |
• – – |
2008-11-18 |
4 |
AS |
$26.20 |
$20,724 |
D/D |
(791) |
28,166 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Public Policy,Gov Affairs |
• – – |
2007-11-07 |
4 |
B |
$24.72 |
$24,720 |
D/D |
1,000 |
18,000 |
2.74 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Public Policy,Gov Affairs |
• – – |
2010-10-15 |
4 |
AS |
$35.00 |
$35,000 |
D/D |
(1,000) |
50,444 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Public Policy,Gov Affairs |
• – – |
2010-10-18 |
4 |
AS |
$36.50 |
$36,500 |
D/D |
(1,000) |
49,444 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
• – – |
2011-07-25 |
4 |
AS |
$49.66 |
$74,882 |
D/D |
(1,500) |
39,074 |
0 |
- |
|
192 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
